The basic science and clinical studies carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Clinical investigators in the Division utilize discoveries from laboratories worldwide to develop and test novel therapeutic approaches to improve patient outcomes.
Adult stem cells channel early development
New research from Stanford shows that skeletal stem cells in mice assume a more primitive developmental state in response to extensive regeneration needs and environmental cues.
Human skeletal stem cell identified
Identification of the human skeletal stem cell by Stanford scientists could pave the way for regenerative treatments for bone fractures, arthritis and joint injuries.
New protein essential for making stem cells
The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.
Study solves mystery of genetic mutation
Stanford researchers used genetic-editing tools and stem cell technology to uncover whether a genetic mutation linked to a heart rhythm disorder was benign or pathogenic.
Neurons quickly generated from blood
Fresh or frozen human blood samples can be directly transformed into patient-specific neurons to study disorders such as schizophrenia and autism, Stanford researchers find.
Conferences and Workshops
Stanford Review of the 60th Annual American Society of Hematology Meeting 2019
Ritz Carlton Hotel, Half Moon Bay, CA
New courses are added regularly— please check back often
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.